What are the next steps for a patient who experienced severe acid reflux symptoms after a single dose of Toradol (Ketorolac) injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acid Reflux After Single Toradol Injection

Discontinue ketorolac immediately and initiate a proton pump inhibitor (PPI) at standard once-daily dosing for 4-8 weeks to treat the NSAID-induced reflux symptoms. 1, 2

Immediate Actions

  • Stop ketorolac permanently – The FDA label explicitly warns that ketorolac can cause serious GI side effects including ulcers and bleeding, and patients should be alert for epigastric pain and dyspepsia, which are your presenting symptoms. 2

  • Start PPI therapy immediately – Begin a standard-dose PPI (such as omeprazole 20 mg, pantoprazole 40 mg, or esomeprazole 40 mg) taken 30-60 minutes before breakfast for optimal acid suppression. 1, 3

  • Duration of PPI treatment – Continue for 4-8 weeks, which is the recommended trial period for reflux symptoms and allows adequate time for healing of any NSAID-induced mucosal injury. 1

Symptomatic Management During PPI Therapy

  • Add alginate-based antacids for breakthrough symptoms while the PPI takes full effect (typically 3-5 days). Alginates form a physical barrier over gastric contents and are specifically recommended for breakthrough reflux symptoms. 1, 4

  • Avoid additional NSAIDs – Do not use ibuprofen, naproxen, aspirin (except low-dose cardioprotective aspirin if prescribed), or any other NSAIDs, as these will perpetuate the gastric irritation. 5, 2

Lifestyle Modifications

  • Weight management and dietary changes – Avoid large meals, late-night eating, and known trigger foods (caffeine, alcohol, chocolate, fatty foods, citrus, tomatoes). 1

  • Elevate head of bed 30-45 degrees to reduce gravitational reflux, particularly at night. 4

Follow-Up Strategy

  • Reassess at 4 weeks – If symptoms resolve completely, attempt to taper the PPI to the lowest effective dose or discontinue after 8 weeks total. 1

  • If symptoms persist beyond 4-8 weeks on PPI – Perform upper endoscopy to evaluate for erosive esophagitis, ulceration, or other pathology, especially given the recent NSAID exposure. 1

  • Red flag symptoms requiring immediate evaluation – Seek urgent care if you develop severe abdominal pain, vomiting blood, black tarry stools, difficulty swallowing, or unexplained weight loss, as these may indicate GI bleeding or perforation from the ketorolac. 2, 6

Future Pain Management

  • Avoid ketorolac permanently – You have demonstrated susceptibility to NSAID-induced GI complications. 5, 2

  • Alternative analgesics – Use acetaminophen as first-line for pain management (up to 3000-4000 mg daily in divided doses if no liver disease). If NSAIDs are absolutely necessary in the future, use the lowest effective dose of ibuprofen (≤1200 mg/day) for the shortest duration (<7 days) with mandatory PPI co-therapy. 5

Key Clinical Pearls

The FDA label for ketorolac specifically warns that serious GI ulcerations and bleeding can occur without warning symptoms, but patients should be alert for epigastric pain and dyspepsia – exactly what you experienced. 2 Even a single dose can trigger these effects in susceptible individuals. 6 The American Gastroenterological Association emphasizes that PPIs are the most effective agents for healing NSAID-associated ulcers and preventing complications. 5 Your symptoms after just one injection indicate you are at high risk for NSAID complications and should avoid this entire drug class whenever possible.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Breakthrough Reflux Symptoms in Hospitalized Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

NSAID Use in GERD Patients: Guidelines for Safe Prescription

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.